Search

Your search keyword '"Buch MH"' showing total 264 results

Search Constraints

Start Over You searched for: Author "Buch MH" Remove constraint Author: "Buch MH"
264 results on '"Buch MH"'

Search Results

1. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2. Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study

3. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

4. Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers

7. Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease

10. T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management

12. Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis

15. ASCORE, a 2-year, observational, prospective study of subcutaneous abatacept for rheumatoid arthritis in clinical practice: 6-month interim analysis of the German cohort

17. A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography:outcome measures for systemic sclerosis-related Raynaud's phenomenon

18. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT

20. P152 Interferon-I activity in early and estblished rheumatoid arthritis (RA) with and without cardiovascular abnormalities in cardiac magnetic resonance (CMR)

21. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

24. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

25. Discordance between the predictors of clinical and imaging remission in patients with early rheumatoid arthritis in clinical practice: implications for the use of ultrasound within a treatment to target strategy

29. FRI0390 European multicentre study validates elf test as biomarker of fibrosis in systemic sclerosis

30. B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use

31. Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease Related Interstitial Lung Diseases

32. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: Provisional core sets of domains and instruments for use in clinical trials

34. Development of a provisional core set of response measures for clinical trials of systemic sclerosis

39. Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

40. Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

44. Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment.

48. C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.

49. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade.

Catalog

Books, media, physical & digital resources